Sb. Leslie et al., ENCAPSULATION OF HEMOGLOBIN IN A BICONTINUOUS CUBIC PHASE LIPID, Biochimica et biophysica acta. Biomembranes, 1285(2), 1996, pp. 246-254
The effects of encapsulating bovine hemoglobin (BHb) in the bicontinuo
us cubic phase formed by monooleoylglycerol and water was investigated
with Fourier transform infrared (FTIR) spectroscopy and X-ray diffrac
tion. Cubic phase was formed in the presence of 1-10 wt% BHb. Studies
using X-ray diffraction reveal that at 0.5-2.5 wt% BHb, the cubic phas
e structure is characterized by the double diamond lattice (Pn3m). At
2.5-5 wt% BHb, coexistence of two cubic phase structures, Pn3m and the
gyroid lattice (Ia3d), was observed while at BHb concentrations highe
r than 5 wt% the gyroid structure persists. FTIR shows there is an inc
rease in intensity of the free upsilon C = 0 (1745 cm(-1)) and a corre
sponding decrease in the intensity of the hydrogen bonded upsilon C =
0 (1720 cm(-1)) as the BHb concentration is increased. The upsilon C-O
-CO peak shifts from 1183 cm(-1) to 1181 cm(-1) as the concentration o
f BHb is raised from 2.5 to 10 wt% indicating BHb may induce subtle ch
anges in the interfacial region of cubic phase monoolein. The bandwidt
h of the upsilon(as)CH(2) stretch (2926 cm(-1)) increased in the prese
nce of 5 wt% BI-IT, compared to samples with 2.5 or 10 wt% BHb. The in
crease in frequency of the upsilon(s)CH(2) stretch (2854 cm(-1)) induc
ed by increasing temperature 20 to 60 degrees C was dampened when BHb
was present compared to samples heated in isotonic buffer. Analysis of
the amide I band at 1650 cm(-1) showed that the secondary structure o
f BHb is not affected by encapsulation in monoolein. In vitro release
studies showed that 45% of the entrapped BHb was released after 144 h
at 37 degrees C. The porous nature of bulk cubic phase was further dem
onstrated by diffusion of K2Fe(CN)(6) and conversion of 73% of the oxy
hemoglobin to methemoglobin after 1 h. These results suggest that the
cubic phase may be useful for encapsulation of Hb as a red cell substi
tute and for the encapsulation and delivery of other bioactive agents.